Justin N. Baker, MD
Justin N. Baker, MD

Justin N. Baker, MD

Associate Member, St. Jude Faculty

  • Chief, Division of Quality of Life and Palliative Care
  • Attending Physician, Quality of Life Service
  • Director, Hematology/Oncology Fellowship Program




BS – Oral Roberts University, Tulsa, Oklahoma (1997)
MD – University of Texas - Health Science Center at San Antonio (2001)

Honors & Awards

  • 2012 The Hastings Center Cunniff-Dixon National Physician Award, Early Career Category
  • 2012 Inaugural St Jude Family Advisory Council Partner in Excellence Award
  • 2012 Fellow, American Academy of Hospice and Palliative Medicine
  • 2011 Memphis Business Journal Top 40 Under 40 Awardee
  • 2010 St Jude Children’s Research Hospital Clinical Improvement Award, Quality of Life Service, Founding Team Member
  • 2008 American Academy of Hospice and Palliative Medicine National Paper Award
  • 2008 American Academy of Hospice and Palliative Medicine National Award for Young Investigators
  • 2007 The University of Tennessee Health Science Center Distinguished Service Award, awarded for Excellence in Clinical Teaching
  • 2006 The University of Tennessee Health Science Center Distinguished Service Award - Awarded for Excellence in Clinical Teaching
  • 2002-2003 American Academy of Pediatrics Scholarship Recipient

Research Interests

  • Pediatric palliative and end of life care
  • Decision making in pediatric oncology
  • Symptom control at end of life in pediatrics
  • Quality of life for pediatric Phase I study participants
  • Communication interventions in pediatric Phase I studies

Selected Publications

Hazen RA, Zyzanski S, Baker JN, Drotar D, Kodish E. Communication about the risks and benefits of phase I pediatric oncology trials. Contemp Clin Trials 41:139-145, 2015. doi: 10.1016/j.cct.2015.01.015.

Hendricks-Ferguson VL, Kane JR, Pradhan KR, Shih CS, Gauvain KM, Baker JN, Haase JE. Evaluation of Physician and Nurse Dyad Training Procedures to Deliver a Palliative and End-of-Life Communication Intervention to Parents of Children with a Brain Tumor. J Pediatr Oncol Nurs Jan 26, 2015. pii: 1043454214563410. Epub ahead of print.

Levine DR, Johnson LM, Mandrell BN, Yang J, West NK, Hinds PS, Baker JN. Does phase 1 trial enrollment preclude quality end-of-life care? Phase 1 trial enrollment and end-of-life care characteristics in children with cancer. Cancer Dec 29, 2014. doi: 10.1002/cncr.29230. Epub ahead of print.

Kaye EC, Baker JN, Broniscer A. Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis. CNS Oncol 3(6):421-31, 2014. doi: 10.2217/cns.14.47.

Levy MH, Smith T, Alvarez-Perez A, Back A, Baker JN, Block S, Codada SN, Dalal S, Dans M, Kutner JS, Kvale E, Misra S, Mitchell W, Sauer TM, Spiegel D, Sutton L, Taylor RM, Temel J, Tickoo R, Urba SG, Van Zyl C, Weinstein SM, Bergman MA, Scavone JL. Palliative care, Version 1.2014. Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 12(10):1379-88, 2014.

Caruso Brown AE, Howard SC, Baker JN, Ribeiro RC, Lam CG. Reported availability and gaps of pediatric palliative care in low- and middle-income countries: a systematic review of published data. J Palliat Med 17(12):1369-83, 2014. doi: 10.1089/jpm.2014.0095.

Johnson LM, Snaman JM, Cupit MC, Baker JN. End-of-life care for hospitalized children. Pediatr Clin North Am 261(4):835-54, 2014. doi: 10.1016/j.pcl.2014.04.012.

Conway AE, Reddick WE, Li Y, Yuan Y, Glass JO, Baker JN, Kun LE, Broniscer A, Patay Z. "Occult" post-contrast signal enhancement in pediatric diffuse intrinsic pontine glioma is the MRI marker of angiogenesis? Neuroradiology 56(5):405-12, 2014. doi: 10.1007/s00234-014-1348-9.

Miller VA, Baker JN, Leek AC, Drotar D, Kodish E. Patient involvement in informed consent for pediatric phase I cancer research. J Pediatr Hematol Oncol
36(8):635-40, 2014. doi: 10.1097/MPH.0000000000000112.

Levine D, Lam CG, Cunningham MJ, Remke S, Chrastek J, Klick J, Macauley R, Baker JN. Best practices for pediatric palliative cancer care: a primer for clinical providers. J Support Oncol 11(3):114-25, 2013.

Baker JN, Leek AC, Salas HS, Drotar D, Noll R, Rheingold SR, Kodish ED. Suggestions from adolescents, young adults, and parents for improving informed
consent in phase 1 pediatric oncology trials. Cancer 119(23):4154-61, 2013.
doi: 10.1002/cncr.28335.

Laubisch JE, Baker JN. Methylnaltrexone use in a seventeen-month-old female with progressive cancer and rectal prolapse. J Palliat Med 16(11):1486-8, 2013. doi: 10.1089/jpm.2012.0600.

Broniscer A, Baker SD, Wetmore C, Pai Panandiker AS, Huang J, Davidoff AM, Onar-Thomas A, Panetta JC, Chin TK, Merchant TE, Baker JN, Kaste SC, Gajjar A, Stewart CF. Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma. Clin Cancer Res 19(11):3050-8, 2013. doi: 10.1158/1078-0432.CCR-13-0306.

Baker JN, Windham JA, Hinds PS, Gattuso JS, Mandrell B, Gajjar P, West NK, Hammarback T, Broniscer A. Bereaved parents' intentions and suggestions about
research autopsies in children with lethal brain tumors. J Pediatr 163(2):581-6, 2013. doi: 10.1016/j.jpeds.2013.01.015.

Reeve BB, Withycombe JS, Baker JN, Hooke MC, Lyons JC, Mowbray C, Wang J, Freyer DR, Joffe S, Sung L, Tomlinson D, Gold SH, Hinds PS. The first step to
integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology clinicians. Pediatr Blood Cancer 60(7):1231-6, 2013. doi: 10.1002/pbc.24463.

Miller VA, Baker JN, Leek AC, Hizlan S, Rheingold SR, Yamokoski AD, Drotar D, Kodish E. Adolescent perspectives on phase I cancer research. Pediatr Blood
60(5):873-8, 2013. doi: 10.1002/pbc.24326.

Fernandez CV, Ruccione K, Wells RJ, Long JB, Pelletier W, Hooke MC, Pentz RD, Noll RB, Baker JN, O'Leary M, Reaman G, Adamson PC, Joffe S; COG Return of
Results Task Force. Recommendations for the return of research results to study participants and guardians: a report from the Children's Oncology Group. J Clin
30(36):4573-9, 2012. doi: 10.1200/JCO.2012.45.2086.

Cousino MK, Zyzanski SJ, Yamokoski AD, Hazen RA, Baker JN, Noll RB, Rheingold SR, Geyer JR, Alexander SC, Drotar D, Kodish ED. Communicating and understanding the purpose of pediatric phase I cancer trials. J Clin Oncol 30(35):4367-72, 2012. doi: 10.1200/JCO.2012.42.3004.

Johnson LM, Church CL, Walsh MF, Baker JN. Clinically significant? Depends on whom you ask. Am J Bioeth 12(10):18-20v. doi: 10.1080/15265161.2012.699159.

Johnson LM, Spraker HL, Coleman JL, Baker JN. An unusual case of Ogilvie syndrome in a pediatric oncology patient receiving palliative care after failed treatment with neostigmine. J Palliat Med 15(9):1042-6, 2012. doi:

Hinds PS, Oakes LL, Hicks J, Powell B, Srivastava DK, Baker JN, Spunt SL, West NK, Furman WL. Parent-clinician communication intervention during end-of-life decision making for children with incurable cancer. J Palliat Med 15(8):916-22, 2012. doi: 10.1089/jpm.2012.0006.

Anghelescu DL, Hamilton H, Faughnan LG, Johnson LM, Baker JN. Pediatric palliative sedation therapy with propofol: recommendations based on experience in
children with terminal cancer. J Palliat Med 15(10):1082-90, 2012. doi: 10.1089/jpm.2011.0500.

Baker JN, Harper J, Kane JR, Hicks J, Ward D, Hinds PS, Spunt SL. Implementation and evaluation of an automated patient death notification policy at a tertiary pediatric oncology referral center. J Pain Symptom Manage 42(5):652-6, 2011. doi: 10.1016/j.jpainsymman.2011.07.002.

Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, da Silva NS, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW,
Baker SJ. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 20;29(30):3999-4006, 2011. doi:

Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE,
Kaste SC, Gajjar A. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol 28(31):4762-8, 2011. doi: 10.1200/JCO.2010.30.3545.

Show More

Anghelescu DL, Faughnan LG, Baker JN, Yang J, Kane JR. Use of epidural and peripheral nerve blocks at the end of life in children and young adults with cancer: the collaboration between a pain service and a palliative care service. Paediatr Anaesth 20(12):1070-7, 2010. doi: 10.1111/j.1460-9592.2010.03449.x.

Baker JN, Kane JR, Rai S, Howard SC, Hinds PS; PCS Research Working Group. Changes in medical care at a pediatric oncology referral center after placement of a do-not-resuscitate order. J Palliat Med 13(11):1349-52, 2010. doi: 10.1089/jpm.2010.0177.

Broniscer A, Baker JN, Baker SJ, Chi SN, Geyer JR, Morris EB, Gajjar A. Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma. Cancer 116(19):4632-7, 2010. doi: 10.1002/cncr.25405.

Yap TY, Yamokoski AD, Hizlan S, Zyzanski SJ, Angiolillo AL, Rheingold SR, Baker JN, Kodish ED; Phase I Informed Consent (POIC) Research Team. Informed
consent for pediatric phase 1 cancer trials: physicians' perspectives. Cancer 116(13):3244-50, 2010. doi: 10.1002/cncr.25158.

Delgado E, Barfield RC, Baker JN, Hinds PS, Yang J, Nambayan A, Quintana Y, Kane JR. Availability of palliative care services for children with cancer in
economically diverse regions of the world. Eur J Cancer 46(12):2260-6, 2010. doi: 10.1016/j.ejca.2010.05.006.

Maurer SH, Hinds PS, Spunt SL, Furman WL, Kane JR, Baker JN. Decision making by parents of children with incurable cancer who opt for enrollment on a phase I trial compared with choosing a do not resuscitate / terminal care option. J Clin Oncol 28(20):3292-8, 2010. doi: 10.1200/JCO.2009.26.6502.

Pritchard M, Burghen EA, Gattuso JS, West NK, Gajjar P, Srivastava DK, Spunt SL, Baker JN, Kane JR, Furman WL, Hinds PS. Factors that distinguish symptoms of
most concern to parents from other symptoms of dying children. J Pain Symptom Manage 39(4):627-36, 2010. doi: 10.1016/j.jpainsymman.2009.08.012.

Young AJ, Kim L, Shu Li, Baker JN, Schmidt M, Camp JW, Barfield RC. Agency and communication challenges in discussions of informed consent in pediatric cancer research. Qual Health Res 20(5):628-43, 2010. doi: 10.1177/1049732310361467.

Pritchard M, Srivastava DK, Okuma JO, Powell B, Burghen E, West NK, Gattuso JS, Spunt SL, Baker JN, Kane J, Furman WL, Hinds PS. Bereaved parents'
perceptions about when their child's cancer-related death would occur. J Pain Symptom Manage 38(4):561-7, 2009. doi: 10.1016/j.jpainsymman.2009.01.005.

Hinds PS, Oakes LL, Hicks J, Powell B, Srivastava DK, Spunt SL, Harper J, Baker JN, West NK, Furman WL. "Trying to be a good parent" as defined by interviews with parents who made phase I, terminal care, and resuscitation decisions for their children. J Clin Oncol 27(35):5979-85, 2009. doi:

Read K, Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Pentz RD, Barfield RC, Baker JN, Santor D, Weijer C, Kodish E. Decision-making by adolescents and parents of children with cancer regarding health research participation. Pediatrics 124(3):959-65, 2009. doi: 10.1542/peds.2008-2878.

Baker JN, Rai S, Liu W, Srivastava K, Kane JR, Zawistowski CA, Burghen EA, Gattuso JS, West N, Althoff J, Funk A, Hinds PS. Race does not influence do-not-resuscitate status or the number or timing of end-of-life care discussions at a pediatric oncology referral center. J Palliat Med 12(1):71-6, 2009. doi: 10.1089/jpm.2008.0172.

Fernandez CV, Gao J, Strahlendorf C, Moghrabi A, Pentz RD, Barfield RC, Baker JN, Santor D, Weijer C, Kodish E. Providing research results to participants: attitudes and needs of adolescents and parents of children with cancer. J Clin Oncol 20;27(6):878-83, 2009. doi: 10.1200/JCO.2008.18.5223.

Baker JN, Hinds PS, Spunt SL, Barfield RC, Allen C, Powell BC, Anderson LH, Kane JR. Integration of palliative care practices into the ongoing care of children with cancer: individualized care planning and coordination. Pediatr Clin North Am 55(1):223-50, 2008. doi: 10.1016/j.pcl.2007.10.011.

Baker JN, Anghelescu DL, Kane JR. Pain still lords over children. J Pediatr 152(1):6-8, 2008.

Harper J, Hinds PS, Baker JN, Hicks J, Spunt SL, Razzouk BI. Creating a palliative and end-of-life program in a cure-oriented pediatric setting: the zig-zag method. J Pediatr Oncol Nurs 24(5):246-54, 2007.

Baker JN, Torkildson C, Baillargeon JG, Olney CA, Kane JR. National survey of pediatric residency program directors and residents regarding education in
palliative medicine and end-of-life care. J Palliat Med 10(2):420-9, 2007.

Baker JN, Barfield R, Hinds PS, Kane JR. A process to facilitate decision making in pediatric stem cell transplantation: the individualized care planning and coordination model. Biol Blood Marrow Transplant 13(3):245-54, 2007.

Hinds PS, Schum L, Baker JN, Wolfe J. Key factors affecting dying children and their families. J Palliat Med 8(suppl 1):S70-8, 2005.

Last update: March 2015